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Abstract
An inadequate supply of iodine during gestation results in damage to the foetal brain
that is irreversible by mid-gestation unless timely interventions can correct the
accompanying maternal hypothyroxinemia. Even mild to moderate maternal
hypothyroxinemia may result in suboptimal neurodevelopment. This review mainly
focuses on iodine and thyroid hormone economy up to mid-gestation, a period
during which the mother is the only source for the developing brain of the foetus. The
cerebral cortex of the foetus depends on maternal thyroxine (T4) for the production of
the 30,3,5-tri-iodothyronine (T3) for nuclear receptor-binding and biological
effectiveness.
Maternal hypothyroxinemia early in pregnancy is potentially damaging for foetal
brain development. Direct evidence has been obtained from experiments on animals:
even a relatively mild and transient hypothyroxinemia during corticogenesis, which
takes place mostly before mid-gestation in humans, affects the migration of radial
neurons, which settle permanently in heterotopic locations within the cortex and
hippocampus. Behavioural defects have also been detected.
The conceptus imposes important early changes on maternal thyroid hormone
economy that practically doubles the amount of T4 secreted something that requires a
concordant increase in the availability of iodine, from 150 to 250–300mg I day21.
Women who are unable to increase their production of T4 early in pregnancy constitute
a population at risk for having children with neurological disabilities. As a mild to
moderate iodine deficiency is still the most widespread cause of maternal
hypothyroxinemia, the birth of many children with learning disabilities may be
prevented by advising women to take iodine supplements as soon as pregnancy starts,
or earlier if possible, in order to ensure that their requirements for iodine are met.
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Introduction
The Declaration for the Survival, Protection and Develop-
ment of Children made after the World Summit for Children
convened by the United Nations in New York in 1989
stated that every mother has the right to an adequate iodine
nutrition to ensure that her newborn child experiences
normal brain development1. For this to occur, an adequate
iodine intake has to be ensured very early in pregnancy and
if all iodine deficiency disorders (IDD) are to be avoided,
whatever their severity. This paper addresses the irrevers-
ible damage to the developing brain that can result from the
deficiency of iodine if not corrected before mid-gestation,
and when it is not accompanied by other environmental
factors that interfere with the capacity of the thyroid gland
to adapt through autoregulatory mechanisms. This paper
will review three aspects of this process:
1. The changes in thyroid hormone metabolism that
occur during the first half of pregnancy, both in the
foetal brain and in the mother;
2. The increase in thyroid hormone synthesis during
pregnancy, and the consequent increased requirement
for iodine; and
3. The differences between the mother and foetus
in the mechanisms by which they adapt to iodine
deficiency (ID).
We will then review the information presently available
on the morphological alterations detected in the brain
of humans and other mammals, especially in the cortex,
that occur before the onset of foetal thyroid hormone
secretory activity, which are therefore related to the state
of the maternal thyroid gland.
A causal relationship between inappropriate maternal
thyroid function and damage to the developing brain has
been suspected since the early 20th century, mostly on the
basis of reports from localities in which ID occurs. It has
only been during the last five decades, however, that this
idea has received increasing, albeit indirect, support from
epidemiological evidence (reviewed in references 2–10).
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A series of studies in Papua New Guinea11,12 and in
Andean regions where endemic goitre with cretinism
occurs13,14, showed that pregnant women in such places
were unable to respond to the onset of pregnancy with an
increase in circulating thyroxine (measured then by serum
protein-bound iodine), which is the normal physiological
response to the onset of pregnancy in women with an
adequate iodine intake. It was also shown that to prevent
the birth of cretins, interventions that corrected the ID
(and the maternal hypothyroxinemia) were required very
early in pregnancy and before mid-gestation at the
latest12,15,16. Since these studies, evidence has accumu-
lated showing that treatment early in pregnancy is
required not only to prevent cretinism, but also to avoid
the lowered intelligence quotient suffered by the rest of
the inhabitants of such areas17 – 21. ID was clearly
recognised, after starvation, as the most frequent world-
wide nutritional cause of mental retardation and cerebral
palsy. The realisation of the scale of the problem has
further increased over recent decades as evidence has
accumulated showing that even mild and moderate
degrees of ID are potentially damaging for neurodevelop-
ment, and interventions are needed early in pregnancy to
prevent them22,23.
Changes in thyroid hormone metabolism that occur
during the first half of pregnancy in the foetal brain
As a result of the development of highly sensitive methods
to estimate very low concentrations of iodothyronines in
foetal fluids and tissues, and the development of
transvaginal, ultrasound-guided puncture of the embryo-
nic cavities to obtain samples from the foetal compartment
without severing vascular connections with the mother,
new and more reliable information has been obtained
during the last two decades regarding maternal–foetal
interrelationships during the first half of pregnancy. This
information, as well as increasing the evidence that the
thyroid hormone transferred from the mother to her foetus
may trigger the biological events very early in pregnancy,
has recently been reviewed extensively and in greater
detail8,10, and so it is briefly summarised here.
Thyroxine (T4), tri-iodiothyronine (T3), reverse
tri-iodiothyronine (rT3) and TSH in fluids of the
foetal compartment
The hormones T4, T3 and rT3 have been found in coelomic
and amniotic fluids from 5.8 to 11 weeks post-menstrual
age (PMA), which is 3.8–9 weeks postconceptional age24.
The concentration of T4 in the coelomic fluid was
positively correlated with the concentration in the
mother’s circulation, but values were extremely low
compared with values recorded for the mother24. The
concentration of T3 was at least ten-fold lower than T4, but
the concentration of rT3 was clearly higher than T4
24; these
findings confirmed the efficiency of the placental barrier.
Concentrations of these hormones in the coelomic fluid
were higher than in the amniotic compartment. Because of
the minute amounts of the iodothyronines found in these
fluids, their possible biological significance has been
questioned.
A second study was performed on serum samples and
up to 17 weeks PMA24. A method was developed to
estimate the concentration of free T4 (fT4), which
confirmed that the concentration of T4 in foetal fluids,
including serum, is more than 100-fold lower than in
maternal serum and the concentration of T3 is even
lower25. However, the proportion of T4 that is not bound
to proteins is much higher, as a result of which the
concentrations of T4 that is available to developing tissues,
namely the free T4, reaches concentrations that are similar
to those that are biologically active in the mothers25.
The fT4 concentration in the foetal fluids is the result
of the interaction between the concentrations of the
T4-binding proteins and the maternal T4, or fT4 that has
passed through the placental barrier. The T4 binding
capacity of the proteins in foetal fluids is determined
ontogenically, it is independent of the maternal thyroid
status, and is far in excess of the amounts of total T4 that
reach the foetal fluids. Thus, the availability of fT4 to
embryonic and foetal tissues is ultimately determined by
the maternal circulating T4 or fT4 and would decrease in
hypothyroxinemic women, even if they are clinically
euthyroid. The results also explain why an efficient barrier
to maternal thyroid hormone transfer is actually necessary:
if T4 and T3 reached the same concentrations in maternal
serum and foetal fluids, the developing tissues would be
exposed to inappropriately high, and possibly
toxic, concentrations of free iodothyronines. Both a
decrease8 and an inordinately high increase26 in the
availability of fT4 and/or fT3 could result in adverse effects
on the timely sequence of thyroid hormone-sensitive
developmental events in the foetal human brain.
It was also observed that the concentration of TSH
circulating in the foetal serum was much higher than in the
mother’s circulation, ranging from 2.9 to 7.2 mIU l21, with
a mean value of 4.31 (SD 0.36) mUI per l25. The samples
analysed in this study had been obtained before severing
the maternal–foetal vascular connections. Although such
values were not anticipated, they actually corroborated
those reported by Thorpe-Beeston et al. throughout foetal
life using samples collected by cordocentesis27, again
without disturbing maternal–foetal connections. Thorpe-
Beeston et al. showed that the foetal serum TSH
concentration throughout pregnancy was well above the
maternal TSH concentration, with foetal concentrations up
to 12 mIU l21 near full term27. Foetal TSH was positively
correlated with foetal fT4 (r ¼ 0.896, P , 0.001)27. Foetal
TSH has a higher bioactivity than maternal TSH, and its
synthesis is not under hypothalamic control, as shown by
the high cord serum TSH concentration found in
anencephalic foetuses28,29. A concentration of foetal TSH
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up to about 12 mIU l21 should not be interpreted as
evidence per se of a hypothalamic-pituitary feedback
response to hypothyroidism, because the reference range
that is used for normal foetuses is 3–14 mIU per l30.
Receptors for TSH have been found throughout the
human foetal brain31 and are believed to mediate cyclic
AMP-independent biological effects of TSH that might be
acting as a growth factor for brain development32. This
possibility is supported by the inclusion of TSH among
the glycoprotein hormone family constituting a subset of
the cystine-knot growth factor superfamily33 and is
discussed further below.
Nuclear thyroid hormone receptors in the
foetal brain
The presence of thyroid hormone receptors (TRs) early in
the development of the human foetal brain supports the
hypothesis that developmental events sensitive to thyroid
hormones might already occur before mid-gestation.
These were detected in the earliest samples of the cerebral
cortex studied 9 weeks PMA by Bernal and Pekonen34,
with the concentration increasing at least ten-fold by
18 weeks35. The occupation of the TRs by T3 was 25–30%
throughout the study period, despite the very low serum
concentration of this iodothyronine. This very important
finding supports the hypothesis that the biological effects
of the hormone might already be occurring in the cerebral
cortex during the first trimester of human pregnancy.
A recent study by Iskaros et al.36 has confirmed the early
expression of THRA and THRB genes in the whole foetal
brain studied between 8.1 and 13.9 weeks PMA.
Expression of the TR-beta1, TR-alpha1 and c-erbA-
alpha2 mRNAs was detected in the 8.1 weeks brain
sample, with TR-alpha1 being the predominant form in
early development, increasing steadily up to 13.9 weeks.
The same happened to the c-erbA-alpha2 mRNA variant.
The expression of TR-beta1 appeared to present a more
complex ontogenic pattern. The results of this study are
indicative of the important role of TRs in mediating the
developmental effects of maternal thyroid hormones early
in pregnancy. The authors moreover suggest that the
repressor activity of unliganded TR-alpha1 on basal gene
transcription37 may also become relevant when the
maternal supply of hormone decreases, and the pro-
portion of the unliganded isoform increases.
Iodothyronines and deiodinase activities in the
foetal brain
The ontogenic patterns of the concentrations of T4, T3
and rT3, and the activity of deiodinases 1, 2 and 3 (D1,
D2 and D3) has now been studied in nine different areas
of the brain of foetuses 13–20 weeks PMA and in
premature infants who died at 24–42 weeks PMA38. The
developmental patterns of the iodothyronines, and the
activity of D2 and D3, showed both spatial and temporal
specificity, but with divergence in the cerebral cortex
and other brain areas, especially the cerebellum (Fig. 1).
The concentration of T3 increased in the cerebral cortex
between 13 and 20 weeks PMA to reach a concentration
similar to those reported in adults, despite the very low
circulating T3 concentration. The data support the idea
that T3 in the human cerebral cortex is also locally
generated from T4, as shown for the foetal rat brain
39.
Considerable D2 activity has indeed been found in the
human cerebral cortex where the activity of D3 was very
low. In contrast, the cerebellar T3 concentration was
much lower than in age-paired cortices and increased
only after mid-gestation, probably because cerebellar D3
activity reached the highest of the values found in the
brain areas that were studied and decreased only after
mid-gestation. Other regions with a high D3 activity such
as the midbrain, basal ganglia, brain stem, spinal cord
and hippocampus, also had a low T3 concentration until
D3 activity started decreasing after mid-gestation. These
findings support the hypothesis that T3 is indeed
required by the human cerebral cortex before mid-
gestation, when the mother is the only source of fT4 in
foetal fluids that is available to tissues. These results
appear to confirm the important roles of D2 and D3 in
the local bioavailability of cerebral T3 during foetal life:
D2 generates T3 from T4, and D3 protects brain regions
from excessive T3 until the hormone is required for their
differentiation.
Changes in thyroid hormone metabolism that occur
during the first half of pregnancy in the mother
The initial transient surge of maternal
circulating FT4
It is obviously of great importance to define the changes in
thyroid hormone synthesis, secretion and metabolism that
occur during normal pregnancy to ensure that the
developing foetal cerebral cortex is supplied with
sufficient T4; this supply is entirely of maternal origin
during the first half of gestation. When it was observed that
the concentration of circulating T4 was higher in pregnant
than in non-pregnant women initially, it was believed that
this was a direct consequence of the oestrogen-stimulated
increase of circulating thyroxine binding globulin (TBG)
and of TBG-moieties that are more highly sialylated and
have a longer biological half-life. The increased concen-
tration of circulating T4 was deemed necessary in order to
keep the concentration of circulating fT4 within the normal
range. However, the expected transient decrease in fT4
followed by a rise in TSH, necessary to attain the new
equilibrium, was not detected.
We now know that the increases in T4 and TBG do not
occur simultaneously, and the fT4 concentration is
actually significantly increased for several weeks before
the concentration of TBG reaches a plateau at mid-
gestation40. The increase in concentration of human
chorionic gonadotropin (hCG) in the maternal and foetal
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compartments is essential to maintain the pregnancy and
is imposed by the presence of the conceptus. During this
period a woman’s thyroid is under the control of the
high concentration of hCG and hCG-related molecules
that have TSH-like activity. During early pregnancy, when
these are at their highest concentration, secretion of both
T4 and T3 is stimulated to the point that maternal
circulating TSH concentration is suppressed. A plot of the
mean maternal serum hCG concentration as a function of
gestational age shows a peak concentration at the end
of the first trimester, with a reciprocal fall in the TSH
concentration (Fig. 2). This phenomenon has even been
observed in a case of thyroid hormone resistance41: the
already very high serum T4 and T3 concentration increased
further at the onset of pregnancy and reached a peak value
when circulating hCG was at its highest at 10–12 weeks
gestation. These changes were accompanied by a
reciprocal fall in serum TSH concentration that was
temporarily suppressed, as already shown in Fig. 2 for
normal women.
This initial adaptation of maternal thyroid physiology to
the presence of the foetus may well be one more example of
the control exerted by the conceptus on the maternal
endocrine system. One possible interpretation is that it is
essential for the conceptus to ensure, for its own benefit, the
high maternal fT4 concentration that is needed for early
neural development. To achieve this, it would be necessary
to override transiently the control of the maternal thyroid
function that is usually exerted through the negative
hypothalamic-pituitary–thyroid feedback mechanism.
The increased production of T4 by the maternal
thyroid requires an increased supply of iodine
Maternal thyroid hormone production during the first half
of pregnancy obviously has to increase very soon after its
onset in order to ensure the early surge in circulating fT4,
and taking into account the increase in plasma volume that
occurs. There is also an increased degradation of the
iodothyronines by the very high activity of D3 in
the uterine-placental unit, possibly a consequence of the
increased oestrogen concentration42. The increase in size
of the maternal T4 pool early in pregnancy has not yet
been defined precisely, and may differ in the same woman
between pregnancies. The information available suggests
that it imposes a considerable burden on the maternal
thyroid gland43. It has been known for years that
hypothyroid women very often have to increase their
dose of T4 during pregnancy
44,45 in order to normalise
their TSH concentration, namely to decrease it below the
upper limits of the normal reference range. A very recent
study has not only confirmed this practice, but
has moreover shown that the levothyroxine dose has
already to be increased by the fifth week of gestation
and by approximately 50% in order to keep the TSH
Fig. 1 Ontogenic changes in the concentrations of T4, T3 and rT3 in the human cerebral cortex (3 upper panels) and cerebellum (3 lower
panels) up to mid-gestation, a developmental period when the mother is the only source of thyroid hormone for the developing foetus
(data from reference 38). In the cerebral cortex D2 activity is high, and D3 is very low; in the cerebellum D2 is lower than in the cerebral
cortex, but D3 activity is very high and inactivates both T4 and T3, preventing their increase in this cerebral area. During this period T4 in
the foetal serum increases about five-fold, from 3 to 15pmolml21, whereas circulating T3 remains very low, about 0.5 pmolml
21 and does
not increase with PMA25. The curves appearing in the different panels were those obtained by curve estimation regression analysis38.
Both cerebral cortex T4 and T3 were fitted to gestational age using a quadratic function with positive regression coefficients, with
P ¼ 0.003 and P ¼ 0.001 respectively. In the cerebellum T4 was fitted to gestational age by a quadratic function with a negative
regression coefficient, P ¼ 0.006.
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concentration within the normal range46. Even this early
and significant increase of the T4 dose, however, failed to
reproduce the first trimester fT4 peak and TSH nadir found
in normal pregnant women. We have proposed that an
even greater increase in the levothyroxine dose might
have been needed if the goal of treatment had been to
reach the physiological trimester-specific fT4 concen-
tration, including the suppressed TSH concentration
characteristic of pregnant women with normal thyroid
status10. This is illustrated in Fig. 2. From such information,
we may conclude that a 50% increase in the daily T4
requirement already imposes a concordant increase in the
iodine intake as soon as pregnancy starts. This possibility
is in conceptual agreement with the marked increase in
iodine requirements during pregnancy and lactation5,43,47,
that is, independent of other possible pregnancy-related
changes that may occur in iodine metabolism.
If we accept the importance of the early maternal fT4
surge imposed by the conceptus, we might be able to
derive the increase in iodine intake—indirectly estimated
from the urinary I excretion (UI)—that would be necessary
to ensure it. An example of this is shown in Fig. 3a, based
on a study performed in pregnant women in Madrid48
where a survey of 2150 schoolchildren using thyroid
palpation and UI concentration disclosed a situation of
very mild ID. The proportion of pubertal girls with goitre,
however, reached 18%. This raised the question of
whether or not their iodine intake would later be sufficient
to meet the increased requirements of pregnancy and
lactation. Indeed, pregnant women from this area were
found to have a median UI concentration of 90–95mg l21
throughout gestation; none of them were either clinically
or subclinically hypothyroid, as none had an increased
serum TSH concentration. The women from the same area
were advised to take supplements of potassium iodide
(KI) of about 250–300mg I day21 from early in their
pregnancy, their UI excretion increased to approximately
180–200mg l21 by the 2nd and 3rd trimesters. During the
1st trimester, a commensurate increase in UI was not
observed in the KI-supplemented women, possibly
because thyroid iodine stores were being replenished.
Despite this, the mothers’ circulating fT4 concentration
increased significantly during the 1st trimester: the median
fT4 values were 16.9 and 19.9 pmol l
21, respectively, for
the non-supplemented and KI-supplemented women.
Moreover, an early peak in fT4 concentration was
observed in the KI-supplemented women, but was absent
in the non-supplemented group. Figure 3b shows the
dependence of the 1st trimester peak of fT4 on the iodine
intake: a correlation was found between the 1st trimester
median fT4 concentration and the median UI concen-
tration corresponding to different studies48–52 that have
used the same protocols and similar methods to determine
Fig. 2 The upper panel shows the increased maternal serum fT4
and fT3 concentrations that are observed during early phases of
normal pregnancy, and their decrease during the second and
third trimester. The lower panel shows the concomitant changes
in maternal circulating human chorionic gonadotrophin (hCG),
imposed by the foetus, responsible for the secretion of T4 and T3
by the mother’s thyroid, and the mirror image in circulating
TSH, maximally suppressed when the hCG concentration (and
fT4 and fT3 concentrations) are highest. Drawn using mean
values reported by Glinoer40. The numbers appearing in the
y-axis of the lower panel should be multiplied by 1000 to calculate
the concentrations of hCG in IU.
Fig. 3 Panel a shows an example of the effects of the
iodine intake on the first trimester fT4 surge and on fT4 values
throughout pregnancy, based on data from a study of pregnant
women with a median urinary iodine of 90–95mg I l21 throughout
gestation, and of those from the same area advised to take KI
supplements (approximately 250mg I day21) from early
pregnancy, and a mean urinary iodine excretion double that of the
non-supplemented women9,48. First, trimester median fT4
values were 16.9 and 19.9 pmol l21, respectively, for the
non-supplemented and KI-supplemented women. The shaded
area corresponds to the fT4 reference range for the general
population. Panel b shows the effect of an iodine intake that is
inadequate for pregnancy on the first trimester fT4 surge. The
latter is blunted when the intake results in an iodine excretion
below 180–200mg I l21, corresponding approximately to an intake
of 250–300mgday21. Median first trimester fT4 and urinary iodine
values are from different studies using the same protocols and
comparable methodology for the determination of fT4
47–51.
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the concentration of fT4. Such results, which are similar to
those obtained by others (i.e. reference 43), emphasise
that a relative maternal ID impairs the capacity of the
maternal thyroid to secrete appropriate amounts of T4, and
the initial fT4 surge is blunted, the more so the greater the
ID43. This impairment is not necessarily detected if the
mother’s serum TSH concentration is being measured
because the concentration usually remains within the
normal range in iodine deficient women who are
otherwise healthy. On the contrary, both an increase in
the serum T3/T4 ratio and the thyroglobulin (Tg)
concentration above the normal range for pregnant
women reflect an increasing degree of maternal ID40,42.
This is discussed further below.
Mechanisms of adaptation of the mother and the
foetus to ID
As summarised in the previous section, the iodine intake
of a pregnant women has to increase by about 100% to
allow her thyroid to produce enough T4 to meet foetal
requirements early in pregnancy. This is often not
ensured, and she faces a relative ID. If this continues
during the second half of pregnancy, the foetal thyroid will
also be iodine deficient. The mother and the foetus,
however, respond differently to this condition; the mother
maintains euthyroidism, whereas the foetus is
hypothyroid.
Maintenance of euthyroidism in iodine deficient
women
The very low concentration of circulating TSH character-
istic of early pregnancy, which results from an increase in
fT4 and fT3 secreted by the thyroid gland under the
influence of hCG, is not the only reason why a relative
maternal hypothyroxinemia may be missed when relying
on an increased TSH concentration for its detection.
A relative ID in the mother rapidly triggers the
autoregulatory mechanisms by which the thyroid adapts
to changes in the availability of iodine. It is important to
realise that these mechanisms occur before changes in the
concentration of circulating TSH, and operate indepen-
dently of thyroid stimulation by TSH, not only in
experimental animals53,54 but also in human beings55.
The immediate and rapid response of a normal thyroid
gland to a low concentration of circulating iodide is an
increase in vascularity, blood flow, iodide trapping, acinar
cell height and hyperplasia. All these changes have been
described without, or before, any significant increase in
circulating TSH concentration or a decrease in T4, and are
correlated with the degree of depletion of iodine in the
gland. Among the many autoregulatory responses that
occur56, the synthesis and secretion of thyroid hormones is
altered and switched towards a preferential use of the
decreasing iodine supply to favour the secretion of T3 over
T4. As a consequence, the concentration of circulating T4
decreases, but the concentration of T3 does not, and may
actually be higher, thus preventing both the appearance of
clinical hypothyroidism57 and an increase in the serum
TSH concentration above the normal reference range58.
Indeed, an increased serum TSH concentration is rarely
found in populations which have ID alone59. Even when
ID is very severe, the increase in circulating TSH is not
commensurate with the very high values observed in
hypothyroid patients with similarly decreased T4 and fT4
concentrations who also have a decreased circulating T3
concentration. An increased concentration of Tg and a
higher T3/T4 ratio are much more frequent finding, even
in mild to moderate ID. In the seminal studies of Glinoer
et al. of the thyroid function of pregnant women from a
population with a moderate ID, TSH concentrations above
the normal range were not found, even among women
with the lowest first trimester fT4 concentration, whereas
an increased T3/T4 molar ratio and serum Tg concentration
were observed from the onset40. Thus, the iodine deficient
pregnant women were hypothyroxinemic, in as much
as they could not maintain the trimester-specific fT4
concentration, but were clinically and biochemically
euthyroid as long as their circulating T3 concentration
was not decreased.
Inhabitants of iodine deficient areas including pregnant
women are, however, frequently incorrectly referred to as
being hypothyroid. This misconception is likely to have
been compounded by the indiscriminate inclusion in
the well known tables enumerating all IDDs3 of findings
from areas with ID (where neurological cretins are born)
together with those from areas where factors other than ID
are impairing thyroid function (where myxoedematous
cretinism prevails)60. To further complicate the issue,
although the maintenance of a normal T3 concentration by
inhabitants of areas with ID alone results in their overall
euthyroidism, they may suffer from selective hypothyroid-
ism of tissues, such as the brain, that depend mostly on T4
for the local availability of T3
3. This continued selective
cerebral hypothyroidism appears to impair cerebral
functions at all ages, until the correction of the ID results
in the normalisation of circulating T4. When ID is present
during early foetal development, however, most of the
damage to the central nervous system (CNS) is no longer
reversed by the later correction of the micronutrient
deficiency.
Hypothyroidism of the iodine deficient foetus
and newborn
It is important to realise that the above comments relate to
an iodine-deficient pregnant woman, but not to her foetus
or newborn infant, as they have not yet developed the
autoregulatory mechanisms for rapid adaptation to
changes in the amounts of circulating iodine61; these
mechanisms only become fully operative after birth. As a
consequence, the shift towards the preferential secretion
of T3, which constitutes the successful adaptive response
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to insufficient iodine of the mother in order to maintain
euthyroidism, does not occur in the foetus. The scarcity of
iodine is accompanied by a decreased synthesis and
secretion of both T4 and T3. The concentration of the latter
is no longer maintained within normal ranges and this
results in hypothyroidism, both clinical and biochemical,
with an above normal concentration of circulating TSH.
The latter change is in conceptual agreement with the
observation that the proportion of newborns with a
concentration in whole blood of TSH.5 mIU l21 is greater
than 3% in populations with ID. This proportion is used to
classify the degree of ID in a population62. Statements
pertaining to the thyroid status of the iodine deficient
mother should not be applied to the foetus, as they are not
necessarily the same. Up to mid-gestation, the possible
damage to the CNS suffered by the foetus would be a
consequence of the hypothyroxinemia of an otherwise
euthyroid mother; after mid-gestation it would be caused
by persisting maternal hypothyroxinemia, aggravated by
hypothyroidism in the foetus.
Morphological alterations in the brain caused by ID
before the onset of foetal thyroid hormone
secretion
As will be seen, the information available regarding the
irreversible damage caused by ID solely through early
hypothyroxinemia of the mother is scarce when compared
with the abundant literature on the damaging effects of
combined maternal hypothyroxinemia and foetal
hypothyroidism.
Effects of ID on human brain development
The neuropathology caused by ID is poorly described
and is restricted to few observations, mostly performed
in adult cretins63. These observations have been made
on people from areas where the mixed type of cretinism
occurs, and it is therefore difficult to characterise
alterations that might have been due merely to early
maternal hypothyroxinemia, as opposed to life-long
exposure to cerebral and/or clinical hypothyroidism.
Information is now being obtained on adult cretins by
non-invasive techniques, such as computerised tomogra-
phy64 or magnetic resonance imaging (MRI)65,66. The
studies of Andean cretins show widespread atrophy of
the cerebral cortex and subcortical structures of the pons
and mesencephalon, with corresponding enlargement of
the basal cisterns, the lateral ventricles and the sulci over
the surfaces of the cerebral cortex64. The MRI images of
three cretins from China showed a remarkably normal
overall appearance, except for hyperintensities on T1
weighted images in the region of the globus pallidus and
substantia nigra65,66.
More informative with respect to possible neuropatho-
logical findings related to early maternal hypothyroxine-
mia caused by ID are the studies summarised by
Jia-Liu et al.67 that had previously documented in greater
detail the results obtained from aborted foetuses in an area
of China where severe ID and cretinism occur68,69. These
foetuses were compared with foetuses from mothers living
in an area where iodine supplements had been given for
five years and foetuses from mothers living in an area
without ID. The results are not easy to interpret as data on
the UI concentration of the inhabitants and their 24 h 131I
uptake indicated that even the supposedly non-deficient
subjects were moderately iodine deficient before iodine
supplementation. The foetuses were obtained at the 4th,
5th, 6th, 7th and 8th months of gestation. No morpho-
metric or cytoarchitectural findings were reported from
foetuses obtained at 4th and 5th month. In the foetuses
obtained at the 6th and 8th month of gestation, some that
came from the iodine deficient population had a lower
brain weight. At 6 months of gestation, the cerebral
cortices of various areas were not well differentiated, only
3 layers were distinguishable, and the cortex nerve cells
consisted mostly of undifferentiated neuroblasts. No
mitoses were observed and apical dendrite budding was
seen, but no basal dendrites were apparent. No
myelination was detected. Two of six foetuses with a
low brain weight had an increased cell density. At
8 months of gestation the cerebral cortices of all areas
examined were clearly differentiated into 6 layers and cells
were recognisable as neuroblasts, pyramidal cells,
granular cells, astrocytes, etc. The dendrites of the
pyramidal cells were developed, yet no myelination was
detected. Heterotopic nerve cells were observed in the
cortical layers and in the underlying white matter in
greater numbers in the foetuses from the iodine deficient
population, indicating that more than the normal number
of neurons were not in their ‘assigned’ layer. Again two out
of five foetuses had a low brain weight and cell density
was increased. The authors concluded that ‘Although the
material studied in the present paper and the above
mentioned differences were relatively small, . . . results
suggest that prenatal ID exhibits certainly a depressive
effect on the brain in some of the foetuses in the endemic
goitre and cretinism areas retarding its development67.
Effects of ID in animal experiments
Experimental studies in sheep
In the 1980s, pioneering and thorough studies of the
effects of ID on brain development in sheep were initiated
in Australia by Hetzel and colleagues. In sheep, a greater
part of brain development occurs in utero as compared
with the human newborn, and newborn lambs are more
mature than babies. Moreover, placentation is quite
different from that in humans, being epitheliochorial in
sheep and haemochorial in humans. Most existing
information indicates that the sheep placenta is also
more impermeable to thyroid hormones than the human
placenta.
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The experimental sheep were fed on a low iodine diet
developed specifically for the studies70, which were fully
reviewed in 199471. After being fed on the diet for five
months the ewes were mated and foetuses were obtained
56, 70, 98 and 140 days later or nearing full term, and
compared with age-matched controls from ewes given the
same diet but supplemented either with KI or iodised oil
injections72. The iodine deficient ewes had a markedly
lower concentration of serum T4 and a higher TSH
concentration. In contrast to the findings in women with
ID, the sheep did not maintain a normal T3 concentration,
and were clinically hypothyroid, as shown by their
frequent foetal loss. Hyperplasia of the foetal thyroid was
evident at day 56, and thyroid hypertrophy by day 70. The
foetal plasma T4 concentration was very low in all iodine
deficient foetuses and did not increase during develop-
ment, whereas an increase was observed in the foetuses
from the iodine-supplemented ewes. At day 140 the iodine
deficient foetuses were goitrous and grossly hypothyroid,
had no wool coat, subluxation of the leg joints, and a
dome-like appearance of the head due to poor skeletal
maturation. Their brains weighed significantly less than
the brains of the controls and their total DNA content was
lower. There were morphological changes in the
cerebellum and cerebral hemispheres clearly indicating
poor maturation. Interestingly, these changes were more
severe than observed in foetuses, which had been
thyroidectomised between day 50 and 60 after con-
ception73. In the cerebellum of iodine deficient lambs
studied 140 days after conception a reduced migration of
cells from the external to the internal granular layer was
observed, and there was an increased density of the
Purkinje cells with reduced arborisation within the
molecular layer. In the visual and motor cortices, as well
as in the CA1 and CA4 regions of the hippocampus, cells
were more densely packed. There was also evidence of
retarded myelination and higher water content. A lower
brain weight and brain DNA content were also seen at day
70, and were interpreted as evidence that neuroblast
multiplication had been impaired. The major phases of
neuroblast multiplication take place in sheep between
days 40 and 80 after conception, which corresponds to
11–18 weeks gestation in humans, that is, before mid-
gestation. This is the period of major interest for the
present review, as it might disclose the possible effects of
maternal hypothyroxinemia alone on brain development,
which occur before foetal hypothyroidism could also play
a role. In this respect it is interesting that the alterations in
brain development observed in the iodine deficient
foetuses at day 140 were more severe than those resulting
from foetal thyroidectomy at days 50 to 6073. This
observation suggests an influence of maternal hypothyr-
oxinemia on the development of the brain of iodine
deficient lambs, because the maternal thyroid status of the
thyroidectomised foetuses was normal. Another important
finding was that injection of iodised oil into iodine
deficient ewes 100 days after conception74 decreased most
of the differences between the foetuses of iodine deficient
dams examined at 140 days and their controls, but brain
weight, cell numbers and counts (density) of synapses in
the cortex were not fully restored. These findings support
the conclusion that an early lack of maternal thyroid
hormones in iodine deficient ewes had irreversibly
affected the brain development of the foetus, despite the
evidence that there is less maternal–foetal transfer of
thyroid hormones in sheep than in humans2,71,75.
Experimental studies in marmosets (Callithix jacchus
jacchus), a primate
The same group of investigators also studied the effects of
a low iodine diet, developed especially for marmosets, on
the brain development of their progeny76. These animals
are also much more mature at birth than human babies.
The brain of iodine deficient marmosets and controls
born to marmosets on the same diet but supplemented
with KI, was only studied at birth, which was 150 days after
conception. The progeny from both 1st and 2nd
pregnancies were studied77. The marmoset mothers
and newborns were more severely iodine deficient and
hypothyroxinemic and had larger goitres during their 2nd
pregnancy, probably because they had been fed on the
diet for a longer period than the six months preceding
the 1st pregnancy. The reproductive performance of the
iodine deficient marmosets in both pregnancies was
similar to that of the controls when assessed in terms of the
number of twins and triplets born. The newborn iodine
deficient marmosets at birth appeared normal in terms of
body weight, but showed some sparsity of hair growth;
there was no evidence of significant skeletal retardation
i.e. normal epiphyseal development. The iodine deficient
marmosets were, however, lacking in strength, and were
unable to cling to their parents, who rapidly abandoned
them. The newborns died within a few days from
malnutrition and hypothermia, thus forfeiting the initial
aim of performing behavioural studies. All the changes
observed in these newborns were more clearly seen in the
2nd litters. There was a greater reduction in brain weight,
especially in the cerebellum, brain cell numbers were
reduced in the cerebellum and brainstem, and cell size
was reduced in the cerebral hemispheres. Histological
examination revealed morphological changes in the
cerebellum and cerebral hemispheres. In the cerebellum
there was an increase in the thickness of the external
germinal layer indicative of impaired cell acquisition.
There was a decrease in total area and molecular layer
area, and an increase in Purkinje cell linear density, and
other changes that implied diminished ascending and
lateral extensions of their dendrites. In the cerebral
hemispheres an increase was observed in the density of
neuronal cell bodies in the granular band and a decrease
in synaptic counts in the layer between the pia mater and
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the supraglandular band of the visual cortex. The greater
severity of the changes in the offspring of the 2nd
pregnancy when compared with the 1st was interpreted
as confirmation of the importance of maternal and foetal
thyroid function in relation to brain development in a
primate, but unfortunately the design of the study did not
permit conclusions regarding the importance of maternal
hypothyroxinemia alone during early foetal brain
development.
Experimental studies in rats
Much experimental work on the effects of ID on the brain
has been done in rats (reviewed in references
2,3,7,8,78,79). The rat shares with man the same type of
haemochorial placenta, but rat pups are born at a more
immature stage of brain development than the human
baby. Morphological changes in the cortex have been
studied in rats with adult-onset ID80, as well as in the
progeny of iodine deficient rat dams, mostly at different
post-natal ages. The experimental designs did not permit
the identification of alterations that could be unequi-
vocally related to early maternal hypothyroxinemia alone,
as they were mostly caused by the combined effect of
maternal hypothyroxinemia with later foetal and post-
natal cerebral hypothyroidism2,81,82. Among the investi-
gations that were most closely related to possible effects
on the brain of early ID and ensuing maternal
hypothyroxinemia are the pioneering studies of McIntosh
et al.83, who obtained data on rat pups at birth. They fed
rat dams with an iodine deficient diet that resulted in
very low concentrations of circulating T4, but the rats
maintained normal weight gain and reproductive effi-
ciency when compared with animals on the same diet that
had been supplemented with KI. This was an important
improvement with respect to previous studies of the
effects of ID. After confirming the iodine deficiency, the
dams were mated and the pups were killed at birth and at
21 days post-natally. At birth the body weight and brain
weight, the whole brain cholesterol concentration, and the
DNA and protein contents were still normal, although
some relatively small changes were found at 21 days after
birth in cerebellar weight, cerebellar and cerebral protein
and cholesterol, whereas the total DNA content remained
the same. At 21 days of age, cell size was decreased in the
cerebellum and cerebral hemispheres, with a relative
increase in cell numbers relative to weight. This study
did not disclose changes that could be attributed
unequivocally to early maternal hypothyroxinemia, but
morphological studies that might have revealed more
specific alterations were not performed.
Li et al.84 also fed rats on an iodine deficient diet
prepared with ingredients obtained from Jixian Village
(Huachuan County, Heilongjiangan Province, China)
where the prevalence of endemic cretinism was then
11%. The controls received the same diet but with added
KI. The serum T4 concentration of iodine deficient dams
was 48% of the value of the controls, and their T3
concentration increased to 113%, both of which are
characteristic autoregulatory responses of the thyroid to a
decreased availability of iodine. Although most of the
morphological studies were performed on pups between
the day of birth and 60 days of age, they also included the
brains of foetuses obtained 16–20 days after conception.
The findings after birth were concordant with those of
McIntosh et al.83: the cerebral and cerebellar histological
findings showed that the density of brain cells was higher,
and the mean neuron size was lower; the branches of
the pyramidal cells were fewer and shorter and the
formation of myelin was reduced; furthermore, disap-
pearance of the cerebellar external granular layer was
delayed, and Purkinje cell morphology was altered.
Findings from both of these studies revealed changes in
brain development similar to those described during the
early post-natal period in hypothyroid pups from dams
chronically fed on goitrogens.
More interesting for the aim of the present review are
the observations of Li et al. on foetal brains84. No changes
were observed at day 16 but at day 17 they described a
decrease in the ratio between the thickness of the cerebral
cortex and the thickness of the brain wall, whereas the
percentage volume of the ventricular zone cells was
increased. From day 18 up to 30 days after birth, the
cerebral cortical cell density was higher in the iodine
deficient progeny. As already pointed out for the findings
of McIntosh et al.83, the study of Li et al.84 did not reveal
effects that could be unequivocally attributed to early
maternal hypothyroxinemia.
Recent experiments on rats, however, have shown that
changes in maternal thyroid hormone availability during
early stages of development, which are equivalent to the
end of the first, and beginning of the second, trimester of
human pregnancy, affect neurogenesis irreversibly. Two
experimental models have been studied so far. One
involved iodine-deficient rat dams85,86, the other involved
rat dams treated for only 3 days with the goitrogen
2-mercapto-1-methyl-imidazole (MMI), a treatment that
resulted in a transient and very mild degree of maternal
thyroid hormone deficiency87. In both experiments the
dams were hypothyroxinemic without being hypothyroid,
either clinically or biochemically, during the period of very
active neurogenesis and migration of radial neurons into
the developing cerebral cortex and hippocampus. This
process occurs during a period when the mother is the
only source of thyroid hormone for the developing foetus.
In the rat the secretion of iodothyronines by the foetal
thyroid starts at 17.5 to 18 days after conception. The final
location of those cells that had been generated during
early periods of neurogenesis was determined in the
young offspring of these dams. This was accomplished by
labelling the cells with 5-bromo-20-deoxyuridine (BrdU),
injected into the dams between days 14 and 16 or 17
and 19, when two major waves of radial migration of
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neurons into the somatosensory cortex are taking place88.
Their final positioning and the cytoarchitecture of the
barrel cortex were studied in pups 40 days after birth,
when the different cerebral structures can be clearly
identified. Figure 4 shows an example of BrdU immuno-
reactive cells in aberrant heterotopic positions in the
40-day old pups born to dams that were chronically fed on
the low-iodine diet (LID). The radial migration of the
BrdU-immunoreactive cells, most of, which were ident-
ified as neurons, was significantly affected, with neurons
appearing in aberrant locations and in cortical and
hippocampal layers inappropriate for their date of birth.
The proportion of neurons reaching the outer layers of the
somatosensory cortex was clearly decreased (Fig. 5). The
alterations in the final location reached by both the cells
formed between days 14 and 16 and those incorporating
BrdU between days 17 and 19 did not correspond to a
delay in the normal migratory pattern, as erroneously
stated89. Neurons formed on these dates are never found
in such locations in pups from normal dams (or in those
from KI-supplemented LID dams (LID þ KI). Cytoarchi-
tectural changes were also found in the hippocampus and
barrel cortex of the primary somatosensory cortex, where
layering was blurred and normal barrels were not
observed. These alterations also indicate an irreversible
derangement of the normal developmental pattern that
could be distinctly traced back to the maternal status
during a very early period of brain histogenesis and
cytoarchitecture. It is very important to realise that the LID
dams were hypothyroxinemic, and showed the prefer-
ential secretion of T3 over T4 that is characteristic of
the autoregulatory responses of the thyroid to an ID.
As described above for the inhabitants of iodine deficient
areas, these animals were not ‘clinically’ hypothyroid as far
as could be assessed from the normal reproductive
competence of the dams (number of foetuses per litter and
foetal weight), and the growth of their pups (normal body
weight at 40-days of age) (Fig. 6 ).
The low iodine diet experiments did not permit a closer
timing of the critical window during development when
the foetal cortex is sensitive to maternal hypothyroxine-
mia, because it took several months of giving the diet for
the dams to become hypothyroxinemic before being
mated. We have attempted to define this period by using
the 3 day MMI model87. Normal dams were treated with
the goitrogen MMI for only 3 days, starting on the morning
of day 12 after conception and stopping on the morning of
day 15. The chemical label BrdU was injected into the
dams between days 14 and 16 or 17 and 19, as in the LID
experiment. Again, the brains of the pups were obtained
at 40-days of age to study their cytoarchitecture. In 83% of
the pups from the MMI—treated dams the same alterations
were found, both in radial neuronal migration into the
neocortex and hippocampus, as well as in cytoarchitecture
of the barrel cortex, that had been observed in the progeny
from LID dams. With the 3 day MMI protocol the maternal
thyroid hormone deficiency was not only limited to a very
precise window in development, but was also quite
moderate: when the goitrogen was stopped the serum T4
and T3 concentrations of dams were still approximately
70% of normal and the concentration of circulating TSH
was not significantly higher than normal. Serum concen-
trations of T4 and T3 reverted to control values within a few
days after stopping treatment with MMI. For the
appearance of all of these abnormalities it was not
necessary to maintain maternal hypothyroxinemia
throughout pregnancy, as done using the LID, because
the short period of maternal thyroid hormone deficiency
created between days 12 and 15 after conception using
MMI was sufficient not only to derange the radial
migration of neurons formed between days 14 and 16,
but also of those generated on days 17–19, after stopping
the goitrogen. The cytoarchitecture of the hippocampus
and barrel cortex also showed the same alterations as in
the LID progeny. The infusion of T4 to correct the decrease
in the maternal thyroid hormone concentration during the
brief period of MMI treatment prevented the alterations of
radial neuronal migrations and cytoarchitecture described
above, whereas infusing T4 was of no benefit when
delayed beyond the critical period of corticogenesis. An
unexpected finding was the induction of behavioural
alterations in a high proportion of the pups born to the
MMI-treated dams. Figure 7 shows that a greater
proportion of 40-days old pups showed a susceptibility
to respond to acoustic stimulation with wild runs when
compared with controls. Results obtained in these
experimental studies are in conceptual agreement with
Fig. 4 Photomicrographs of coronal sections of primary
somatosensory cortex and CA1 of hippocampus showing BrdU
immunoreactive (BrdUþ) cells in control (LID þ KI) and LID pups
at 40 days postnatal age. Examples are shown both for subgroups
of dams injected with BrdU at days 14, 15, 16 post-conception
(BrdU þ , E14-16) and at days 17, 18, 19 (BrdUþ , E17-19). The
letters wm identifies the subcortical white matter. Unpublished
photomicrographs from the study of Lavado-Autric et al.85.
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those recently reported by others86,90–92. The results from
the two studies summarised above85,87 are the first to
confirm the irreversibility of the early brain damage related
to maternal hypothyroxinemia. We believe that the
implications for humans regarding the possible damaging
effects of early maternal hypothyroxinemia on neurode-
velopment are supported by the observation in human
foetal brains from an area where ID is endemic of an
increased proportion of heterotopic neurons in locations
different from their ‘assigned’ layers67.
Conclusions
Early in pregnancy the conceptus imposes important
changes on maternal thyroid hormone requirements that
result in an increased pool of circulating fT4, with a surge
early during the first trimester of pregnancy. This surge is
proposed as a biologically relevant event controlled by the
conceptus to ensure that its developing cerebral cortex is
provided with enough substrate to generate adequate
amounts of T3 to bind to its nuclear receptors, and results
in biological effects. During this period TSH secretion is
suppressed and circulating TSH is not necessarily
Fig. 5 The radial migration of the BrdU-immunoreactive (BrdUþ ) cells, most of, which were identified as neurons, was significantly
affected by the maternal hypothyroxinemia caused by chronic ID in rats (LID model)85, with BrdU þ cells appearing in aberrant
locations and in cortical and hippocampal layers inappropriate for their date of birth. The proportion of neurons reaching the outer
layers of the somatosensory cortex was clearly decreased, whereas the proportion of cells found in subcortical white matter (wm)
increased. Alterations in the final location reached by the cells were observed both for those ‘born’ between 14 and 16days
post-conception (E14-16) and those incorporating BrdU between days 17 and 19 post-conception (E17-19). Layers I, II–III, IV, V
and VI correspond to the somatosensory cortex, with wm corresponding to the subcortical white matter. The layers of the
hippocampal CA1 and CA3 areas are stratum alveus (alb), stratum oriens (ori), stratum pyramidale (soma), stratum radiatum (rad),
stratum moleculare (mol), inner plexiform stratum (int), stratum pyramidale (soma) and outer plexiform stratum (ext). Asterisks
identify statistically significant differences between pups from both groups of LID dams, when compared with pups born to dams
fed on LID þ KI and to normal dams, fed on stock pellets.
Fig. 6 Results obtained with the 3dMMI experimental model in
rats. The histogram shows significant differences between
the percentage of BrdUþ cells found in different layers of the
somatosensory cortex and in subcortical white matter (wm) of 40
day-old pups born to normal rat dams and to dams treated for
only 3 days with MMI, started 12 days post-conception withdrawn
at 15 days post-conception (3dMMI12 group). The alterations in
the migratory pattern of the BrdUþ cells (BrdU injected on days
14, 15 and 16 post-conception (E14-16) were prevented when T4
was infused during the phase of MMI treatment (3dMMI12 þ T413
group), but had become irreversible when the infusion was
delayed beyond the critical window at the onset of corticogenesis
(3dMMI12 þ T415 group). Results are from the study by Auso´
et al.87.
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increased above the normal range in cases when there is
an inadequate first trimester fT4 surge.
Women who are unable to increase their production
of T4 early in pregnancy would constitute a population at
risk for neurological disabilities in their children. This
conclusion is strongly supported by experimental evi-
dence in rats that shows that even a moderate and
transient period of maternal thyroid hormone insuffi-
ciency during periods of active neocorticogenesis irrever-
sibly affects cortical and hippocampal cytoarchitecture,
with neurons reaching heterotopic locations. As a mild to
moderate ID is still the most widespread cause of maternal
hypothyroxinemia in Western societies, the birth of many
children with learning disabilities may be prevented by
advising women to take iodine supplements as soon as
pregnancy starts, or earlier if possible.
It would appear that a daily iodine intake resulting in a
urinary iodine concentration of approximately 180–
200mg l21 is the minimum needed to avoid blunting of
the early serum fT4 surge. This requires an intake of
approximately 250–300mg of iodine a day, which is in
agreement with other recent estimates5,44.
It follows that the learning disabilities of future
generations can be prevented by promoting the following:
the universal use of iodised salt throughout life; the use of
iodine supplements, both as vitamin–mineral mixtures
that contain KI, or as KI tablets, whenever available, from
the onset of pregnancy (or earlier if pregnancy is
planned), just as folate supplements are extensively
promoted for pregnant women without prior confirmation
of a folate deficiency.
Additional remarks regarding human ID
As indicated in the introduction, in the present review we
have not considered the likely further increase in iodine
requirements in those places where ID is not the only
nutritional condition that affects thyroid function, as
occurs in areas where myxoedematous, or mixed type,
cretinism is predominant60,93,94. Factors such as goitrogens
in food, selenium deficiency and endocrine disruptors,
impair the response of the thyroid through autoregulatory
mechanisms; both circulating T4 and T3 are then
insufficient, and the offspring are increasingly hypothyr-
oid. Prevention of IDD in such areas may well require
additional intervention strategies.
We also have not reviewed the evidence that maternal
hypothyroxinemia early in pregnancy and unrelated to an
ID also affects neurodevelopment of the offspring95,96
further increasing the frequency of learning disabilities in
children born in developed societies. Such handicaps
might be prevented if early maternal hypothyroxinemia
were detected and corrected. ID, however, still remains
the major cause of such disabilities worldwide, including
industrialised societies97.
Because of the frequency with which some observations
are incorrectly interpreted, we wish to emphasise here two
important examples, already referred to above.
First, the regulation of thyroid function through the
hypothalamic-pituitary–thyroid negative feedback loop is
so ingrained in our thinking that in clinical practice a low
circulating T4 concentration is automatically associated
with a high TSH concentration, and with hypothyroidism,
either clinical or subclinical. Only when there is evidence
that TSH is not increased is the individual patient studied
for evidence of causes other than primary thyroid failure.
Thus, the definition of ‘hypothyroxinemia’, namely that
the concentration of T4 or fT4 has decreased without an
increase in the concentration of TSH above the normal
reference range is intuitively rejected. Moreover, very
efficient mechanisms controlling thyroid function other
than the negative feedback loop are overlooked or, very
frequently, poorly known to most physicians, who
associate them with iodine overload, but not with ID.
Because of this widespread assumption, statements
referring to increases in the TSH concentration in
otherwise healthy iodine deficient pregnant women
should always indicate that they occur within the normal
reference range40,43. As this is not always the case, when a
circulating TSH concentration above the reference range is
not found, it is wrongly concluded that the women are not
Fig. 7 Results obtained with the 3dMMI experimental model in
rats. The percentage of pups responding to an acoustic stimulus
with ‘wild runs’ is markedly increased in the progeny of the
3dMMI12 dams when compared with pups born to normal dams
(left upper panel). In some of these pups, the ‘wild run’ was
followed by a clonic-tonic seizure (left lower panel). Panels on the
right represent the cumulative frequency of pups from the same
groups that responded with wild runs (upper panel) or wild runs
followed by seizures (lower panel) at the intervals after onset of
the acoustic stimulus that are shown in the abscissa. The
asterisks indicate significant differences between groups of pups.
Rat pups were exposed to 95–100dB for a maximum of 90 s. The
acoustic challenge was interrupted sooner if the animal responded
with a seizure. Results are from the study by Auso´ et al.87.
Brain development in pregnancy 1565
iodine-deficient, and the possibility that their iodine intake
is inadequate for pregnancy and lactation is overlooked.
Second, and equally dangerous, is the reliance on
changes in foetal and cord serum TSH values as indicators
of foetal thyroid hormone status. The high foetal TSH
concentrations reported by Thorpe-Beeston et al.27 and
later observed by us25 had already been described by
Fisher et al.98, who reported mean values of 9.6 (SD 0.93)
mIU l21 at 22–34 weeks of gestation, and 8.9 (SD 0.93)
mIU l21 at 38–40 weeks. Such values have also been
confirmed quite recently by the analysis of results from a
database of 695 cord serum TSH values obtained from
premature and full term neonates, grouped by gestational
age at birth99: mean values ranged between 6.7 (SD 4.8) to
7.9 (SD 5.2) mIU l21. The individual values were likely to
be positively correlated with the fT4 concentration,
because the TSH/fT4 ratio was constant. The negative
correlation that would be expected if the TSH levels were
regulated through the hypothalamic-pituitary–thyroid
feedback loop was definitely excluded (personal com-
munication by the authors).
Foetal TSH that is not under hypothalamic control has a
very high bioactivity and is very poorly sialylated100.
Contrary to our previous (and mistaken) statements
regarding the possible extrahypophyseal site of synthesis
of this TSH10,101, which were prompted by the high
concentrations found in foetal serum before full matu-
ration of hypothalamic-pituitary vascular connections at
mid-gestation, it has now been definitely established that
the TSH circulating in the normal foetus is secreted by the
foetal pituitary gland as it is undetectable in the serum of
foetuses in whom the hypophysis is absent102. Circulating
TSH contains isoforms that differ in the degree of
sialylination of the carbohydrate chains that modify their
biological potency100. The TSH circulating predominantly
in the serum of a normal foetus is of an isoform with a high
biological/immunological (B/I) ratio, and its secretion is
independent of hypothalamic control28,29. But the foetal
pituitary also secretes a highly sialylated TSH isoform with
a lower B/I that is under hypothalamic-pituitary negative
feedback control. This isoform predominates in the
circulation of foetuses with primary hypothyroidism, as
well as in normal and hypothyroid adults, including
pregnant women100. The hypothalamic-pituitary negative
feedback control of the secretion of this TSH isoform is
already operative in the foetus by mid-gestation, as
demonstrated by cases of intrauterine diagnosis and
treatment of congenital primary hypothyroidism, based on
elevated levels of foetal serum TSH. These concentrations
decreased with interventions correcting the hypothyroid
condition of the foetus103,104. In all reported cases of foetal
primary hypothyroidism, the concentration of TSH was
much higher than 12 mIU l21, and well above the
threshold values used in neonatal thyroid screening of
$25 mIU l2l. Thus, it now appears that cord serum TSH
concentrations up to 12–14 mIU l21are normal, they are
not under hypothalamic control, they are positively
correlated with the foetal fT4 concentration, and should
not be used to assess foetal thyroid status. These values,
moreover, appear to be influenced by perinatal stress105.
Much higher values, in the region of the threshold used in
neonatal screening programs of $25 mIU l21, are to be
expected when TSH secretion is responding to changes in
thyroid hormone availability through hypothalamic-
pituitary negative feedback control.
When cord blood or neonatal screening TSH
concentrations are used as criteria to define the degree
of ID in a locality62, values below 5 mIU l21 whole
blood, which are equivalent to approximately 10 mIU l21
of serum, are considered normal: an ID is suspected
when higher concentrations are found in more than 3%
of newborns. In a large survey in northern China106
adverse effects on the neurodevelopment of children
were found in the group of newborns with a cord blood
TSH concentration above this threshold, and mainly in
the groups of children with levels above 20 mIU l21
serum. Changes in the cord blood TSH concentration,
from a median of 7.07 mIU l21 to 9.00 mIU l21 in infants
born to women with mild–moderate ID, who had
received a daily supplement of 150mg I, as compared
with infants from non-supplemented mothers, have been
interpreted as evidence of undesirable and potentially
harmful effects of maternal iodine supplementation for
the child107. However, the data actually showed an
improvement in foetal thyroid status when mothers
were given iodine supplements, because cord blood
fT4 increased in concentration, and Tg concentration
decreased. The observed increase in cord serum TSH
concentration is actually the expected change, consider-
ing that there is a positive correlation between the foetal
TSH concentration and fT4. It should not be interpreted
as indicating a potentially harmful effect of iodine
supplement on the mother. If, as discussed above, this
foetal TSH is acting as a growth factor for the brain32,33,
the observed increase might actually be a beneficial
consequence of maternal iodine supplementation during
pregnancy. Continuing reference to the above study107
as evidence against iodine supplementation during
pregnancy should be avoided, because the evidence is
likely to be an incorrect interpretation of physiological
changes in cord serum TSH concentrations.
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